174 related articles for article (PubMed ID: 38274229)
41. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy.
Graham PS; Kaidonis G; Abhary S; Gillies MC; Daniell M; Essex RW; Chang JH; Lake SR; Pal B; Jenkins AJ; Hewitt AW; Lamoureux EL; Hykin PG; Petrovsky N; Brown MA; Craig JE; Burdon KP
BMC Med Genet; 2018 May; 19(1):71. PubMed ID: 29739359
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
[TBL] [Abstract][Full Text] [Related]
45. Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization Study.
Yazdanpanah N; Yazdanpanah M; Wang Y; Forgetta V; Pollak M; Polychronakos C; Richards JB; Manousaki D
Diabetes Care; 2022 Jan; 45(1):169-177. PubMed ID: 34758976
[TBL] [Abstract][Full Text] [Related]
46. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes.
Elbana KA; Salem HM; Abdel Fattah NR; Etman E
Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644
[TBL] [Abstract][Full Text] [Related]
47. Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study.
Ghanbari F; Yazdanpanah N; Yazdanpanah M; Richards JB; Manousaki D
Diabetes; 2022 Jun; 71(6):1324-1337. PubMed ID: 35234851
[TBL] [Abstract][Full Text] [Related]
48. Identification and comprehensive analysis of ferroptosis-related genes as potential biomarkers for the diagnosis and treatment of proliferative diabetic retinopathy by bioinformatics methods.
Cao D; Wang C; Zhou L
Exp Eye Res; 2023 Jul; 232():109513. PubMed ID: 37207868
[TBL] [Abstract][Full Text] [Related]
49. Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes.
Cheung CY; Hui EY; Lee CH; Kwok KH; Gangwani RA; Li KK; Chan JC; Woo YC; Chow WS; Yuen MM; Wong RL; Fong CH; Xu A; Wong DS; Sham PC; Lam KS
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5518-5524. PubMed ID: 27768789
[TBL] [Abstract][Full Text] [Related]
50. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
Mohan A; Saxena S; Kaur A; Ali W; Akduman L
Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs (-146a, -21 and -34a) are diagnostic and prognostic biomarkers for diabetic retinopathy.
Helal HG; Rashed MH; Abdullah OA; Salem TI; Daifalla A
Biomed J; 2021 Dec; 44(6 Suppl 2):S242-S251. PubMed ID: 35304162
[TBL] [Abstract][Full Text] [Related]
52. Statin use and the risk of progression to vision threatening diabetic retinopathy.
Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.
Torus B; Korkmaz H; Ozturk KH; Şirin FB; Argun M; Şevik S; Tök L
Minerva Endocrinol (Torino); 2023 Mar; 48(1):42-50. PubMed ID: 33213115
[TBL] [Abstract][Full Text] [Related]
54. Polymorphisms in the CTSH gene may influence the progression of diabetic retinopathy: a candidate-gene study in the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).
Thorsen SU; Sandahl K; Nielsen LB; Broe R; Rasmussen ML; Peto T; Grauslund J; Andersen ML; Mortensen HB; Pociot F; Olsen BS; Brorsson C
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1959-65. PubMed ID: 26245339
[TBL] [Abstract][Full Text] [Related]
55. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease.
Chen J; Ruan X; Sun Y; Lu S; Hu S; Yuan S; Li X
EBioMedicine; 2024 Jan; 99():104934. PubMed ID: 38103512
[TBL] [Abstract][Full Text] [Related]
56. CD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy.
Huang J; Zhou Q
Front Endocrinol (Lausanne); 2022; 13():907396. PubMed ID: 35937822
[TBL] [Abstract][Full Text] [Related]
57. Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes.
Wang J; Xin X; Luo W; Wang R; Wang X; Si S; Mo M; Shao B; Wang S; Shen Y; Chen X; Yu Y
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):25. PubMed ID: 33351059
[TBL] [Abstract][Full Text] [Related]
58. Association between retinol binding protein 4 and diabetic retinopathy among type 2 diabetic patients: a meta-analysis.
Han W; Wei H; Kong W; Wang J; Yang L; Wu H
Acta Diabetol; 2020 Oct; 57(10):1203-1218. PubMed ID: 32405713
[TBL] [Abstract][Full Text] [Related]
59. Diabetic retinopathy is not associated with carbonic anhydrase gene polymorphisms.
Abhary S; Burdon KP; Gupta A; Petrovsky N; Craig JE
Mol Vis; 2009 Jun; 15():1179-84. PubMed ID: 19536309
[TBL] [Abstract][Full Text] [Related]
60. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
